Puma Biotechnology Inc (PBYI) Q2 2025 Earnings Call

Investor webinar replay

Watch the replay and follow the connected company analysis, news, and investor updates for Puma Biotechnology Inc.

Watch the replay

Replay transcript excerpt

WEBVTT 00:00:00.000 -- 00:00:05.060 Good afternoon. My name is LaTonya, and I will be your conference call operator today. 00:00:05.060 -- 00:00:08.400 At this time, all participants are in a listen-only mode. 00:00:08.400 -- 00:00:12.700 After the speaker's foremost remarks, there will be a question and answer session. 00:00:12.700 -- 00:00:17.080 If you would like to ask a question during that time, simply press the star key, then 00:00:17.080 -- 00:00:21.800 the number one on your telephone keypad. If you would like to withdraw your questions, 00:00:21.800 -- 00:00:26.560 please press star 2. If you should require operator assistance during the conference, 00:00:26.560 -- 00:00:30.860 please press star 0. As a reminder, this call is being recorded. 00:00:30.860 -- 00:00:35.680 I would now like to turn the conference over to your host today, Marianne Ohanison, senior 00:00:35.680 -- 00:00:41.180 director of IR for Puma Biotechnology. You may begin your conference. 00:00:41.180 -- 00:00:45.520 Thank you, LaTonya. Good afternoon, and welcome to Puma's conference call to discuss 00:00:45.520 -- 00:00:49.120 our earnings results for the second quarter of 2025. 00:00:49.120 -- 00:00:54.140 Joining me on the call today are Ellen Arbach, chief executive officer, president, and 00:00:54.140 -- 00:01:00.060 chairman of the board of Puma Biotechnology, Maximo Noguez, chief financial officer, 00:01:00.060 -- 00:01:05.360 Heather Blaber, senior vice president of marketing, and Roger Storms, senior vice president 00:01:05.360 -- 00:01:07.220 of sales. 00:01:07.220 -- 00:01:11.800 After the close today, Puma issued a news release detailing earnings results for second 00:01:11.800 -- 00:01:13.900 quarter 2025. 00:01:13.900 -- 00:01:18.980 That news release, the slides that Roger ...